Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cypress Bioscience confirms Ramius' buyout offer
Yahoo/AP
Tuesday, July 20, 2010 - 3:34pm
tags:
M&A, Cypress Bioscience, Ramius
FDA approves Lannett’s generic for Sandoz weight-loss drug
Bizjournals.com
Tuesday, July 20, 2010 - 3:31pm
tags:
Sandoz, obesity, Lannett, generics, FDA
Earnings Preview: Analysts eye Lilly drug pipeline
Yahoo/AP
Tuesday, July 20, 2010 - 3:29pm
tags:
earnings, Eli Lilly
A Bill Would Give The FDA Mandatory Recall Powers
Pharmalot
Tuesday, July 20, 2010 - 11:22am
tags:
FDA, healthcare reform, recalls
Novartis chief stands firm on Alcon bid
Fierce Pharma
Tuesday, July 20, 2010 - 11:03am
tags:
Novartis, Joe Jimenez, M&A, Alcon
Swine Flu Fizzles Out; WHO May Declare End to Pandemic Alert
Bloomberg
Tuesday, July 20, 2010 - 11:01am
tags:
WHO, swine flu, H1N1, GSK, Roche, Sanofi
Glaxo Said to Have Paid $1 Billion Over Paxil Suits
Bloomberg
Tuesday, July 20, 2010 - 11:00am
tags:
GSK, settlements, Paxil, antidepressants
FDA Accepts AFREZZA Complete Response Resubmission and Sets Target Action Date
Yahoo
Tuesday, July 20, 2010 - 9:24am
tags:
FDA, Afrezza, inhaled insulin, diabetes
Forest Labs' profit drops 55% on charges
Marketwatch
Tuesday, July 20, 2010 - 9:03am
tags:
earnings, Forest Labs
J&J cuts 2010 profit view again
Yahoo/Reuters
Tuesday, July 20, 2010 - 8:54am
tags:
JNJ, guidance, earnings
Down to the Bone: Is an HIV Drug's Link to Fractures Underplayed?
BNET Pharma
Tuesday, July 20, 2010 - 8:25am
tags:
Viread, Gilead Sciences, HIV
J&J 2nd-quarter net up 7.5%, revenue up 0.6%
Marketwatch
Tuesday, July 20, 2010 - 8:07am
tags:
JNJ, earnings
Biogen Earnings Exceed Forecasts
TheStreet.com
Tuesday, July 20, 2010 - 7:56am
tags:
Biogen Idec, earnings
Actelion reports growth in second quarter of 2010
Zenopa
Tuesday, July 20, 2010 - 7:54am
tags:
earnings, Actelion
An Undisclosed Conflict On The FDA Avandia Panel?
Pharmalot
Tuesday, July 20, 2010 - 7:28am
tags:
Avandia, GSK, advisory panels
Arena Weight Loss Drug Looks Promising
Seeking Alpha
Tuesday, July 20, 2010 - 7:20am
tags:
Arena Pharmaceuticals, obesity
King Pharma shares rise on Goldman Sachs upgrade
Yahoo/AP
Tuesday, July 20, 2010 - 7:19am
tags:
upgrades, King
Vertex: A New Era In HCV Drug Development
Seeking Alpha
Tuesday, July 20, 2010 - 7:18am
tags:
HCV, Vertex Pharmaceuticals, Schering Plough, Telaprevir
Pfizer halts third study of experimental pain drug
Yahoo/AP
Monday, July 19, 2010 - 6:47pm
tags:
Pfizer, pain, clinical trials, tanezumab
Abbott Labs Loves Merck More Than Gilead
Motley Fool
Monday, July 19, 2010 - 6:46pm
tags:
Abbott Laboratories, Merck, Gilead Sciences, Truvada, HIV, Kaletra, Inverness Medical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.